Originally published September 27 2005
Another Vioxx trial underway
by Mike Adams, the Health Ranger, NaturalNews Editor
Two months after arthritis patient Frederick "Mike" Humeston was prescribed Vioxx, the otherwise healthy man was stricken with heart trouble. He's now suing Merck & Co., the makes of Vioxx, for knowing about the possible complications and not warning patients.
A lawyer for a man who blames Vioxx for his heart attack told jurors Wednesday that the man had an active lifestyle but was stricken within two months of beginning to take the painkiller.
During opening statements in a product liability case against Vioxx maker Merck & Co., attorney Chris Seeger said client Frederick "Mike" Humeston resorted to the drug to address persistent pain from a Vietnam War shrapnel wound.
Humeston, 60, of Boise, Idaho, survived and is now suing Whitehouse Station-based Merck, saying the company knew the risks posed by the popular arthritis drug but failed to warn consumers adequately.
Holding hands with wife Mary, Humeston limped into the courthouse Wednesday morning, favoring the damaged knee that earned him a Purple Heart and later prompted his doctor to recommend Vioxx.
The trial, one of about 2,475 Vioxx cases pending in New Jersey, is the first one to go to trial since a Texas jury found Merck responsible for the death of a Vioxx user whose widow blamed the drug for his heart arrhythmia.
In that case, the jury found Merck to blame and ordered a $253 million award, though that amount is expected to be dramatically reduced because of a Texas law capping punitive damages in civil cases.
The suit was filed in New Jersey -- the company's home state -- to prevent Merck from trying to move the case to federal court, which lawyers perceive as less friendly to plaintiffs.
"This isn't a guy who neglected his health," said Seeger, saying Humeston's cholesterol levels and blood pressure were normal and that he never smoked.
The trial is shaping up as a battle of expert witnesses trying to simplify complicated medical evidence for the seven-woman, three-man jury that will hear the case over the next four to six weeks.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml